Flourish Collective
Convertible Note in 2022
Flourish Collective is a digital platform designed to support new and expecting families by enhancing access to maternal healthcare and wellness services. It features a marketplace that offers evidence-based products and vetted maternal wellness services, along with a funding mechanism that allows friends and family to contribute towards a positive birth and parenting experience. By providing resources for pregnancy, birth, and postpartum care, Flourish Collective aims to bridge gaps in maternal healthcare, making essential wellness services accessible to all mothers from pregnancy through motherhood.
Vartega
Seed Round in 2022
Vartega Inc. is a technology development firm based in Golden, Colorado, that specializes in the recycling of carbon fiber, a strong and lightweight material used across various industries, including aerospace, automotive, wind energy, and sporting goods. Founded in 2014, Vartega employs a patented recycling process to transform carbon fiber scrap and waste into low-cost, high-quality products suitable for mass-market applications. The company’s offerings include semi-continuous, chopped, and milled carbon fiber, which can be utilized in thermoplastics, nonwoven fabrics, and molding compounds. By diverting carbon fiber waste from landfills, Vartega aims to enhance the sustainability of these industries, contributing to improved fuel economy and significant reductions in greenhouse gas emissions.
Drusolv Therapeutics
Convertible Note in 2022
Drusolv Therapeutics is a clinical-stage drug company focused on developing a high-dose oral statin, known as ocustatin, for the early intervention of age-related macular degeneration (AMD). Targeting patients in the intermediate stage of the disease, Drusolv aims to address the limited treatment options available to prevent progression to late-stage vision loss. Ocustatin was developed at Harvard University and has demonstrated significant efficacy in a successful proof-of-concept clinical trial, which showed a 75% reduction in the progression to late-stage blindness. Led by founder and CEO John Edwards, who has extensive experience in AMD, Drusolv Therapeutics is committed to providing innovative solutions for patients facing this debilitating condition.
Rellevate
Seed Round in 2022
Rellevate, LLC is a financial services company based in Stamford, Connecticut, founded in 2019. It specializes in providing digital banking services that empower consumers to access, move, and manage their money seamlessly. Rellevate offers a range of products, including digital accounts with interest, a Visa debit card, and services such as Pay Any-Day, bill payment, and money transfer facilities. Primarily targeting employers, Rellevate aims to enhance employee retention, reduce turnover, and increase satisfaction and loyalty by enabling employees to take greater control over their financial well-being through its innovative offerings.
Dynamic Light
Convertible Note in 2022
Dynamic Light, founded in May 2018 and based in Austin, Texas, specializes in the development of innovative blood flow imaging technology. The company's mission is to enhance patient care and reduce healthcare costs through real-time, continuous, and quantitative visualization of blood flow in living tissues. Dynamic Light's technology allows surgeons to obtain high-resolution images of blood flow and perfusion without the need for dyes or procedural interruptions. This capability supports improved decision-making during surgical procedures, ultimately leading to better outcomes for patients.
Sonnest
Convertible Note in 2022
Sonnest is a clinical healthcare company focused on developing innovative solutions for the myocardium. It specializes in an electrically sensitive imaging agent that assesses and monitors the heart's perfusion, structure, and function. This voltage-activated agent responds to ultrasound and the local electric field of the heart, allowing clinicians to determine the viability of heart tissue. By providing advanced imaging technology, Sonnest aims to enhance patient care and improve health outcomes. Additionally, the company addresses customer inquiries through various channels, including phone, email, and online applications, ensuring accessible support for its clients.
Global Neighbor
Seed Round in 2021
Global Neighbor develops directed energy technologies for environmentally friendly weed control. Their first product, the Weed Seed Destroyer (WDSD), attaches to combine harvesters and treats chaff with directed energy to render weed seeds non-viable before they are discarded into fields.
Vartega Inc. is a technology development firm based in Golden, Colorado, that specializes in the recycling of carbon fiber, a strong and lightweight material used across various industries, including aerospace, automotive, wind energy, and sporting goods. Founded in 2014, Vartega employs a patented recycling process to transform carbon fiber scrap and waste into low-cost, high-quality products suitable for mass-market applications. The company’s offerings include semi-continuous, chopped, and milled carbon fiber, which can be utilized in thermoplastics, nonwoven fabrics, and molding compounds. By diverting carbon fiber waste from landfills, Vartega aims to enhance the sustainability of these industries, contributing to improved fuel economy and significant reductions in greenhouse gas emissions.
Rx Bandz
Convertible Note in 2021
Rx Bandz is a manufacturer focused on developing advanced auto-injectors designed to deliver a variety of injectable medications tailored for active patients. The company specializes in creating reliable and waterproof devices that address the challenges faced by patients, medics, and first responders in carrying emergency self-injectable medications. Their product offerings target critical areas such as anaphylaxis, pain management, non-compressible hemorrhage, opioid overdose, anti-chemical warfare, and vaccines. In addition to its current line of auto-injectors, Rx Bandz is engaged in ongoing device and formulation development to enhance the efficacy and accessibility of these vital medical solutions.
WorkEQ is a business development and employment agency focused on fostering a flexible and productive work-life balance for organizations. The company has developed a contact tracing and health monitoring platform aimed at enhancing workplace safety by swiftly identifying potential exposure to infectious diseases among employees. This platform allows organizations to access critical data regarding symptom onset and infectious periods, enabling prompt responses to prevent viral outbreaks. By prioritizing health and safety, WorkEQ not only enhances employee engagement and productivity but also promotes a more inclusive work environment.
kegg is a fertility health tracking device from a San Francisco based company founded in 2017 that combines fertility tracking with pelvic floor exercises. The device analyzes changes in cervical fluids to detect the fertile window and ovulation up to seven days in advance, providing users with information to guide conception decisions. By collecting data from cervical fluids, it aims to support women’s health through improved diagnosis, monitoring, and planning related to fertility.
Work & Mother
Convertible Note in 2021
Work & Mother provides lactation suites in commercial buildings and a supportive app for working mothers. These suites offer hospital-grade equipment, cleaning services, refrigeration, and additional resources via the app, helping employers meet legal obligations and promoting workplace wellbeing.
Ictero Medical
Convertible Note in 2021
Ictero Medical is a medical device company focused on developing minimally invasive solutions for gallbladder ablation, specifically targeting high-risk patients with gallstone disease. Their innovative tool is designed to operate within an interventional radiology suite, allowing for the defunctionalization of the gallbladder using only minimal local anesthesia. This approach offers physicians an alternative to traditional surgery, providing patients with the advantages of surgical treatment while mitigating associated risks. By prioritizing safety and efficacy, Ictero Medical aims to enhance patient care in the management of gallbladder conditions.
PATH EX
Convertible Note in 2021
PATH EX develops a proprietary technology for extracorporeal blood cleansing, focusing on treating sepsis by selectively removing intact bacteria and toxins from human blood. This innovative approach aims to reduce diagnostic times, treatment costs, readmission rates, and sepsis-related deaths.
Galen Data
Series A in 2021
Founded in 2016 and based in Houston, Texas, Galen Data offers a configurable, scalable software platform for medical devices. This platform securely collects, stores, visualizes, and analyzes data, enabling companies to focus on innovation without needing expertise in software design or cybersecurity.
Machfu develops and maintains applications and infrastructure for industrial Internet of Things, enabling data analytics and visualization across mobile tablets and computers. The company offers MachFU, a device that allows machines to communicate and connects industrial assets to legacy systems and cloud platforms, as well as Mach-IT, which enables multiple pieces of equipment to communicate directly with information processing systems. Its platform provides edge-to-cloud connectivity through secure gateways and integrated monitoring solutions for methane detection and machine health tracking, delivering real-time insights and predictive maintenance that reduce downtime and operating costs.
Materna Medical
Series A in 2021
Materna Medical, Inc. is a medical device company based in Mountain View, California, focused on developing innovative solutions to reduce maternal childbirth-related injuries during vaginal delivery. Established in 2010, the company addresses significant unmet needs in women's pelvic health, positioning itself within a $6 billion market. Materna Medical aims to transform the standard of care in obstetrics and gynecology by leveraging advanced technologies and a diverse team of engineers, scientists, and commercial leaders. The company’s mission is to empower women to safeguard their pelvic health through its novel medical devices.
Work & Mother
Pre Seed Round in 2021
Work & Mother provides lactation suites in commercial buildings and a supportive app for working mothers. These suites offer hospital-grade equipment, cleaning services, refrigeration, and additional resources via the app, helping employers meet legal obligations and promoting workplace wellbeing.
Ikonopedia
Series D in 2021
Ikonopedia, LLC is a developer of a cloud-based breast study interpretation and reporting system designed to enhance the efficiency of radiologists. Established in 2012 and headquartered in Dallas, Texas, the company provides a comprehensive Mammography Reporting System that ensures compliance with the Mammography Quality Standards Act (MQSA) and offers customizable report macros for individual practitioners. Additionally, Ikonopedia's SonoPro application supports radiologists during diagnostic breast ultrasound exams. The solutions are designed to automate tracking and monitoring of patients, ensuring clear and consistent clinical reports that adhere to the ACR BI-RADS® Atlas 5th Edition. The system is compatible with various modern devices and is utilized by telemammography and satellite clinics, ultimately aiming to improve patient safety, streamline workflows, and enhance the overall experience for radiologists and their staff.
Sonnest is a clinical healthcare company focused on developing innovative solutions for the myocardium. It specializes in an electrically sensitive imaging agent that assesses and monitors the heart's perfusion, structure, and function. This voltage-activated agent responds to ultrasound and the local electric field of the heart, allowing clinicians to determine the viability of heart tissue. By providing advanced imaging technology, Sonnest aims to enhance patient care and improve health outcomes. Additionally, the company addresses customer inquiries through various channels, including phone, email, and online applications, ensuring accessible support for its clients.
CellChorus
Convertible Note in 2021
CellChorus is a biotechnology company specializing in dynamic, single-cell analysis for biopharmaceutical applications. Its proprietary TIMING™ platform employs visual artificial intelligence to assess cell activation, movement, and killing over time, enhancing the understanding of cellular functions and states. By integrating insights from various analytical methods, including single-cell RNA sequencing and flow cytometry, CellChorus provides healthcare organizations with a comprehensive view of cellular phenotypes and interactions. This technology supports the development of immuno-oncology therapies and other biopharmaceutical innovations, facilitating more effective treatments through a deeper understanding of cell behavior.
VenoStent
Seed Round in 2021
VenoStent develops bioabsorbable smart polymer wraps for vascular surgeries. Its flagship product, SelfWrap, is a perivascular wrap designed to reduce failures at the vein-artery junction in dialysis patients by promoting outward vein growth and providing custom-fit mechanical support. The company's technology acts as an external stent, reducing surgery time, infection risk, and wound reopening while improving vein usability and durability.
Allotrope Medical
Series A in 2021
Allotrope Medical Inc. is a Houston-based medical device company that specializes in manufacturing surgical devices aimed at enhancing surgical procedures. The company's flagship product, StimSite, is an intuitive handheld device designed specifically to assist surgeons in quickly and accurately identifying ureters during operations. This device not only aids in ureter localization but also functions as a blunt dissection tool, streamlining the surgical process. By employing a simple single-button design, Allotrope Medical's device eliminates the need for additional pre and post-operative procedures, thereby improving efficiency in pelvic surgeries. Established in 2016, the company focuses on innovative solutions that enhance surgical accuracy and patient safety.
Your Fare
Convertible Note in 2021
Your Fare, Inc., established in 2016 and based in San Francisco, California, specializes in developing an application that enables restaurants to manage all their online orders through a single platform. The company's ordering management system allows restaurateurs to consolidate orders from various sources, replace traditional online ordering tablets, and monitor daily sales via one dashboard. Additionally, Your Fare helps manage third-party delivery services, integrating them into a unified interface. This streamlined approach aims to enhance operational efficiencies and profit margins for restaurants by automating the handling of online meal orders and reducing order delivery time.
Chosen Diagnostics
Convertible Note in 2020
Chosen Diagnostics is a developer of innovative biomarker diagnostic kits designed to enhance healthcare delivery for neonates. The company's primary focus is on diagnosing a prevalent and life-threatening bowel disease in preterm infants. Its diagnostic kit provides more accurate results compared to existing options, facilitating earlier medical intervention. By enabling healthcare professionals to detect critical conditions sooner, Chosen Diagnostics aims to improve treatment outcomes for thousands of low birth weight preterm infants, ultimately contributing to better health and survival rates in this vulnerable population.
kegg
Convertible Note in 2020
kegg is a fertility health tracking device from a San Francisco based company founded in 2017 that combines fertility tracking with pelvic floor exercises. The device analyzes changes in cervical fluids to detect the fertile window and ovulation up to seven days in advance, providing users with information to guide conception decisions. By collecting data from cervical fluids, it aims to support women’s health through improved diagnosis, monitoring, and planning related to fertility.
ConnectUs Global
Seed Round in 2020
ConnectUs Global develops real-time location tracking solutions using dual-frequency UWB and Wi-Fi-based badges and tags, with receivers and sensors to deliver indoor positioning data tied to building information, floorplans and zones. The platform supports asset and personnel tracking, enables streamlined inventory management, improves production efficiency and enhances employee safety.
ImmunoGenes
Series A in 2020
ImmunoGenes is a biotech company specializing in the development of monoclonal antibodies through its innovative platform technology. Utilizing genetically-modified mice and rabbits that overexpress the neonatal Fc receptor, ImmunoGenes' patented IMG-AbS technology enhances immune responses, resulting in a greater number and diversity of B cell clones. This capability allows for the generation of high-quality monoclonal antibody candidates, which are essential for pharmaceutical and biotech companies in their search for unique therapeutics and diagnostics. In addition to antibody development, ImmunoGenes offers custom antibodies and transgenic services, collaborating with various pharmaceutical, institutional, and academic partners to improve the efficiency of identifying new therapeutic targets and candidates. The company is committed to discovering, developing, and commercializing monoclonal antibodies aimed at challenging and novel targets.
ImmunoGenesis
Venture Round in 2020
ImmunoGenesis is a biotechnology company focused on developing innovative immune therapies aimed at treating tumors that exhibit low levels of activated T cells or possess other mechanisms of immune resistance. The company specializes in creating immuno-oncology therapeutics designed to address the challenges of immunologically cold cancers, including prostate, colorectal, and pancreatic cancer. By targeting critical mechanisms of immune resistance, ImmunoGenesis aims to facilitate effective immune responses in these difficult-to-treat cancer types, ultimately providing healthcare professionals with access to advanced therapies that enhance treatment options for patients.
TrueSpot
Seed Round in 2020
TrueSpot is a leader in geo-intelligent operations, specializing in high-fidelity real-time location services and asset mapping. The company's innovative platform enables the tracking and locating of assets both on and off campuses. By transforming location data into geo-intelligence, TrueSpot enhances operational efficiency through a comprehensive understanding of workflows and spatial awareness. In the retail automotive sector, this capability is exemplified through products such as Lot Management 360, TrueRecon, and Fixed Ops 360. Additionally, in the healthcare industry, TrueSpot offers MedSpot360, further demonstrating its versatility in applying geo-intelligent solutions to optimize asset management and streamline processes across various sectors.
kegg is a fertility health tracking device from a San Francisco based company founded in 2017 that combines fertility tracking with pelvic floor exercises. The device analyzes changes in cervical fluids to detect the fertile window and ovulation up to seven days in advance, providing users with information to guide conception decisions. By collecting data from cervical fluids, it aims to support women’s health through improved diagnosis, monitoring, and planning related to fertility.
PyrAmes
Seed Round in 2020
PyrAmes is a healthcare technology company that has created an innovative, paper-thin, flexible device for non-invasive blood pressure monitoring. This ultra low-power device is designed to deliver continuous and accurate blood pressure measurements wirelessly, making it suitable for patients of all ages, from newborns to seniors. PyrAmes aims to transform healthcare delivery by providing a platform that enables healthcare providers to conduct pain-free blood pressure monitoring, particularly benefiting vulnerable populations such as neonates.
Nexus A.I.
Seed Round in 2020
Nexus A.I. is a Chicago-based company founded in 2014 that specializes in application software leveraging Artificial Intelligence for staffing and team building. The software is designed to streamline the process of identifying and curating talent, including freelancers, based on specific skills, competencies, and customizable attributes. By analyzing employee skills and experience, Nexus A.I. helps organizations build effective teams, identify skill gaps, and create staffing efficiencies. The platform enables users to align work with skills, track skill progression, and organize teams around project-based tasks, thereby improving overall utilization rates. With a global presence, Nexus A.I. supports users in over fifty countries across six continents, fostering inclusivity and enhancing talent management for various campaigns.
Rellevate
Pre Seed Round in 2020
Rellevate, LLC is a financial services company based in Stamford, Connecticut, founded in 2019. It specializes in providing digital banking services that empower consumers to access, move, and manage their money seamlessly. Rellevate offers a range of products, including digital accounts with interest, a Visa debit card, and services such as Pay Any-Day, bill payment, and money transfer facilities. Primarily targeting employers, Rellevate aims to enhance employee retention, reduce turnover, and increase satisfaction and loyalty by enabling employees to take greater control over their financial well-being through its innovative offerings.
Proov is a company that specializes in developing rapid response urine test strips for measuring progesterone, a hormone essential for confirming ovulation and supporting conception. Unlike traditional in-home tests that primarily measure hormones like LH, FSH, and estrogen during the early menstrual cycle, Proov's tests provide a more comprehensive assessment by specifically tracking progesterone levels. This capability allows women to not only predict ovulation but also to identify potential hormonal imbalances that may contribute to infertility or miscarriage. By enabling women to monitor their hormonal health at home, Proov offers a cost-effective alternative to fertility clinics and IVF treatments, empowering them to take control of their reproductive health.
Allotrope Medical
Convertible Note in 2020
Allotrope Medical Inc. is a Houston-based medical device company that specializes in manufacturing surgical devices aimed at enhancing surgical procedures. The company's flagship product, StimSite, is an intuitive handheld device designed specifically to assist surgeons in quickly and accurately identifying ureters during operations. This device not only aids in ureter localization but also functions as a blunt dissection tool, streamlining the surgical process. By employing a simple single-button design, Allotrope Medical's device eliminates the need for additional pre and post-operative procedures, thereby improving efficiency in pelvic surgeries. Established in 2016, the company focuses on innovative solutions that enhance surgical accuracy and patient safety.
Your Fare
Convertible Note in 2020
Your Fare, Inc., established in 2016 and based in San Francisco, California, specializes in developing an application that enables restaurants to manage all their online orders through a single platform. The company's ordering management system allows restaurateurs to consolidate orders from various sources, replace traditional online ordering tablets, and monitor daily sales via one dashboard. Additionally, Your Fare helps manage third-party delivery services, integrating them into a unified interface. This streamlined approach aims to enhance operational efficiencies and profit margins for restaurants by automating the handling of online meal orders and reducing order delivery time.
Renovion, Inc. is a clinical-stage pharmaceutical company based in Chapel Hill, North Carolina, focused on developing innovative therapies for chronic inflammatory respiratory diseases. Founded in 2013, the company is dedicated to addressing conditions such as cystic fibrosis, severe asthma, chronic obstructive pulmonary disease, and bronchiectasis. Its flagship product, Arina-1, is a nebulized therapy that targets airway inflammation and infection, utilizing a novel approach to improve patient outcomes. Renovion's mission is to provide effective treatment options for patients suffering from mucus-related diseases, thereby enhancing the quality of care in respiratory health. The company was previously known as The Repairion Group, Inc. before rebranding in December 2015.
VenoStent
Seed Round in 2020
VenoStent develops bioabsorbable smart polymer wraps for vascular surgeries. Its flagship product, SelfWrap, is a perivascular wrap designed to reduce failures at the vein-artery junction in dialysis patients by promoting outward vein growth and providing custom-fit mechanical support. The company's technology acts as an external stent, reducing surgery time, infection risk, and wound reopening while improving vein usability and durability.
Mi Padrino
Convertible Note in 2020
Mi Padrino is an event planning service dedicated to assisting families in organizing and funding celebrations rooted in Hispanic traditions, such as Quinceañeras, weddings, and baptisms. Founded by Kim Gamez, who recognized the complexities involved in coordinating these significant events, Mi Padrino offers a user-friendly platform that allows users to manage and share event details with friends and family worldwide. This innovative service streamlines the planning process by providing an all-in-one solution for event organization, enabling users to easily share their special moments and receive financial contributions from loved ones, regardless of their location. Through Mi Padrino, families can celebrate their traditions with greater ease and efficiency.
PATH EX
Convertible Note in 2020
PATH EX develops a proprietary technology for extracorporeal blood cleansing, focusing on treating sepsis by selectively removing intact bacteria and toxins from human blood. This innovative approach aims to reduce diagnostic times, treatment costs, readmission rates, and sepsis-related deaths.
PyrAmes
Convertible Note in 2020
PyrAmes is a healthcare technology company that has created an innovative, paper-thin, flexible device for non-invasive blood pressure monitoring. This ultra low-power device is designed to deliver continuous and accurate blood pressure measurements wirelessly, making it suitable for patients of all ages, from newborns to seniors. PyrAmes aims to transform healthcare delivery by providing a platform that enables healthcare providers to conduct pain-free blood pressure monitoring, particularly benefiting vulnerable populations such as neonates.
Machfu develops and maintains applications and infrastructure for industrial Internet of Things, enabling data analytics and visualization across mobile tablets and computers. The company offers MachFU, a device that allows machines to communicate and connects industrial assets to legacy systems and cloud platforms, as well as Mach-IT, which enables multiple pieces of equipment to communicate directly with information processing systems. Its platform provides edge-to-cloud connectivity through secure gateways and integrated monitoring solutions for methane detection and machine health tracking, delivering real-time insights and predictive maintenance that reduce downtime and operating costs.
kegg
Convertible Note in 2019
kegg is a fertility health tracking device from a San Francisco based company founded in 2017 that combines fertility tracking with pelvic floor exercises. The device analyzes changes in cervical fluids to detect the fertile window and ovulation up to seven days in advance, providing users with information to guide conception decisions. By collecting data from cervical fluids, it aims to support women’s health through improved diagnosis, monitoring, and planning related to fertility.
Osperity Inc., founded in 2011 and based in Calgary, Canada, specializes in enterprise visual monitoring solutions for managing field operations, assets, and facilities across various industrial sectors such as mining, construction, oil and gas, and security. The company's core offering is the Osprey Reach platform, a cloud-based system that integrates sensor data, analyzes images and videos using advanced computer vision, and delivers actionable insights to stakeholders via visual reports and alerts. This enables clients to enhance operational efficiency, security, safety, and remote inspections while optimizing labor productivity and managing assets more effectively.
Galen Data
Seed Round in 2019
Founded in 2016 and based in Houston, Texas, Galen Data offers a configurable, scalable software platform for medical devices. This platform securely collects, stores, visualizes, and analyzes data, enabling companies to focus on innovation without needing expertise in software design or cybersecurity.
Zibrio
Convertible Note in 2019
Zibrio specializes in advanced balance diagnostics. It leverages NASA technology originally used on astronauts, along with machine learning, to measure subtle changes in balance. Incorporated in 2017, Zibrio aims to empower users to manage their health proactively by providing insights into their balance profiles.
Allotrope Medical
Convertible Note in 2019
Allotrope Medical Inc. is a Houston-based medical device company that specializes in manufacturing surgical devices aimed at enhancing surgical procedures. The company's flagship product, StimSite, is an intuitive handheld device designed specifically to assist surgeons in quickly and accurately identifying ureters during operations. This device not only aids in ureter localization but also functions as a blunt dissection tool, streamlining the surgical process. By employing a simple single-button design, Allotrope Medical's device eliminates the need for additional pre and post-operative procedures, thereby improving efficiency in pelvic surgeries. Established in 2016, the company focuses on innovative solutions that enhance surgical accuracy and patient safety.
VenoStent
Pre Seed Round in 2019
VenoStent develops bioabsorbable smart polymer wraps for vascular surgeries. Its flagship product, SelfWrap, is a perivascular wrap designed to reduce failures at the vein-artery junction in dialysis patients by promoting outward vein growth and providing custom-fit mechanical support. The company's technology acts as an external stent, reducing surgery time, infection risk, and wound reopening while improving vein usability and durability.
Ictero Medical
Convertible Note in 2019
Ictero Medical is a medical device company focused on developing minimally invasive solutions for gallbladder ablation, specifically targeting high-risk patients with gallstone disease. Their innovative tool is designed to operate within an interventional radiology suite, allowing for the defunctionalization of the gallbladder using only minimal local anesthesia. This approach offers physicians an alternative to traditional surgery, providing patients with the advantages of surgical treatment while mitigating associated risks. By prioritizing safety and efficacy, Ictero Medical aims to enhance patient care in the management of gallbladder conditions.
SIERA.AI
Seed Round in 2019
SIERA.AI enhances industrial vehicle operations by offering a SaaS platform that digitizes compliance paperwork, monitors equipment health, and tracks safety violations. This is achieved through AI-enabled sensors, improving productivity and safety across various industries such as manufacturing, logistics, and energy.
Ikonopedia
Series C in 2019
Ikonopedia, LLC is a developer of a cloud-based breast study interpretation and reporting system designed to enhance the efficiency of radiologists. Established in 2012 and headquartered in Dallas, Texas, the company provides a comprehensive Mammography Reporting System that ensures compliance with the Mammography Quality Standards Act (MQSA) and offers customizable report macros for individual practitioners. Additionally, Ikonopedia's SonoPro application supports radiologists during diagnostic breast ultrasound exams. The solutions are designed to automate tracking and monitoring of patients, ensuring clear and consistent clinical reports that adhere to the ACR BI-RADS® Atlas 5th Edition. The system is compatible with various modern devices and is utilized by telemammography and satellite clinics, ultimately aiming to improve patient safety, streamline workflows, and enhance the overall experience for radiologists and their staff.
MacroFab is a technology-enabled electronics manufacturing platform and service provider with a network of North American factories, enabling hardware technology companies of all sizes to prototype and manufacture printed circuit board assemblies (PCBAs) at any scale. The company offers an easy-to-use platform that reduces upfront costs and complexity by integrating design data, providing early risk feedback, and coordinating production as conditions change. Through enhanced transparency and traceability across the design-to-manufacture workflow, MacroFab helps teams move from concept to market quickly while maintaining resiliency in dynamic environments. It manufactures millions of custom PCBA products annually, combining software-driven workflow management with manufacturing capability to support prototyping, low-volume production, and scalable manufacturing.
TeVido BioDevices
Venture Round in 2019
TeVido BioDevices, Inc. is a biotech start-up based in Austin, Texas, focused on developing innovative tissue-engineered products for reconstructive surgery. Established in 2016, the company utilizes a platform technology that integrates 3D bio-printing with patients' living cells to create custom grafts. These grafts specifically address unmet needs in reconstructive and cosmetic surgery, particularly for individuals who have lost skin color due to scarring or disease. TeVido's approach aims to enhance the quality of life and self-esteem of those affected by disfigurement while also having potential applications in wound healing and broader cosmetic procedures. Through its advanced manufacturing techniques and cellular therapy innovations, TeVido BioDevices is poised to significantly improve surgical outcomes in the field of reconstructive medicine.
ClearCam
Seed Round in 2018
ClearCam Inc. is a medical technology company based in Austin, Texas, founded in 2018. It specializes in developing innovative tools that enhance visibility for surgeons during laparoscopic procedures. The company's flagship product, the ClearCam Kelling, is a laparoscope lens cleaning device designed to maintain a clear visual field without necessitating the removal of the laparoscope from the surgical site. This device attaches directly to the scope and does not require additional supplies, thereby streamlining surgical processes, saving time, and improving overall safety for patients and medical staff alike.
TeVido BioDevices
Seed Round in 2018
TeVido BioDevices, Inc. is a biotech start-up based in Austin, Texas, focused on developing innovative tissue-engineered products for reconstructive surgery. Established in 2016, the company utilizes a platform technology that integrates 3D bio-printing with patients' living cells to create custom grafts. These grafts specifically address unmet needs in reconstructive and cosmetic surgery, particularly for individuals who have lost skin color due to scarring or disease. TeVido's approach aims to enhance the quality of life and self-esteem of those affected by disfigurement while also having potential applications in wound healing and broader cosmetic procedures. Through its advanced manufacturing techniques and cellular therapy innovations, TeVido BioDevices is poised to significantly improve surgical outcomes in the field of reconstructive medicine.
Your Fare
Seed Round in 2018
Your Fare, Inc., established in 2016 and based in San Francisco, California, specializes in developing an application that enables restaurants to manage all their online orders through a single platform. The company's ordering management system allows restaurateurs to consolidate orders from various sources, replace traditional online ordering tablets, and monitor daily sales via one dashboard. Additionally, Your Fare helps manage third-party delivery services, integrating them into a unified interface. This streamlined approach aims to enhance operational efficiencies and profit margins for restaurants by automating the handling of online meal orders and reducing order delivery time.
ScribeRule
Seed Round in 2018
software development company specializing in the security, control, and sharing of information and data
Theratome Bio
Series A in 2018
Theratome Bio, Inc. is a biotechnology company that specializes in developing therapeutics derived from the secretome of adult stem cells. The company’s lead product, Thera-101, is an injectable biologic drug aimed at treating ischemic brain injuries, including strokes. In addition to its focus on brain injuries, Theratome Bio explores various therapeutic areas including autoimmune diseases, chronic neurodegenerative diseases, ischemic heart disease, organ transplants, orthobiologics, peripheral arterial disease, and wound healing. By harnessing the healing factors naturally produced by adult human stem cells, Theratome Bio aims to provide innovative treatments that promote regeneration and repair of damaged tissues. Established in 2011 and based in Indianapolis, Indiana, Theratome Bio is committed to adhering to industry standards in the manufacturing, shipping, storage, and application of its therapeutic products.
Riders Share
Seed Round in 2018
Riders Share Inc is a motorcycle sharing community that operates an online marketplace for peer-to-peer motorcycle rentals. Founded in 2015 and based in Newport Beach, California, the platform allows individuals to rent motorcycles from private owners, offering a diverse selection that ranges from low-capacity models to high-end custom bikes. Riders can easily book their desired motorcycle online, bypassing the complexities of traditional rental processes. The company boasts a significant inventory of over 2,000 motorcycles available for rent across major U.S. cities, including Los Angeles, San Francisco, New York, and Miami. To ensure safety and reliability, Riders Share employs machine learning for vetting riders and provides insurance options, fostering a secure environment for both renters and bike owners.
Glycos Biotechnologies
Seed Round in 2018
Glycos Biotechnologies, Inc. is a biotechnology company based in Houston, Texas, specializing in the development and production of personalized nutritional foods aimed at addressing dietary deficiencies in individuals with various health conditions. Founded in 2007, the company offers innovative products such as Monomega, a pre-digested monoglyceride form of essential omega-3 fatty acids; Monomega-V, which combines essential fatty acids with vitamins for enhanced delivery; and Peptide Plus, a line of plant-based hypoallergenic protein hydrolysates designed for personalized gut functions. Glycos Biotechnologies is also engaged in partnerships with the fuels and chemicals industries, enabling the production of high-value products from non-food feedstocks while promoting sustainability and reducing carbon footprints.
PolyPort
Seed Round in 2018
PolyPort Inc. is a company that specializes in developing encryption software tailored for three-dimensional (3D) assets and objects. Founded in 2016 and based in Chamblee, Georgia, PolyPort enables designers, engineers, and artists to create prototypes for various applications, including automotive mechanisms, architectural designs, and creative projects. The software allows users to encrypt their designs, manage permissions, and track their 3D assets effectively. It is designed to integrate seamlessly into existing workflows without the need for plugins or additional hardware, allowing for immediate collaboration and secure sharing of content. PolyPort prioritizes the protection and enforcement of intellectual property while ensuring that users can utilize their preferred tools and shortcuts across different platforms.
DNAtrix
Convertible Note in 2016
DNAtrix, Inc. is a clinical-stage biotechnology company based in Houston, Texas, with an additional office in San Diego, California. The company specializes in developing virus-driven immunotherapies for cancer treatment, focusing initially on glioblastoma, a highly aggressive and currently untreatable brain tumor. Its lead product, DNX-2401, is a modified oncolytic virus derived from a common cold virus, designed to selectively target and kill cancer cells. This innovative approach has shown promising results, with over 35 patients treated and positive early outcomes reported. In addition to DNX-2401, DNAtrix is advancing other candidates such as DNX-2440 and DNX-2450 for solid tumors, as well as MYX-135 for hematological malignancies. The company also has a strategic partnership with Valo Therapeutics, further enhancing its research and development capabilities in the field of cancer immunotherapy.
Infrastructure Networks
Venture Round in 2016
Infrastructure Networks provides services for the acquisition and delivery of natural energy resources required to power a modern economy. It eliminates the frustrations associated with managing and scaling remote communications by providing end-to-end customer connectivity solutions. By leveraging the global scale and adoption of a leading standards-compliant technology, recognized technology leaders, along with 24/7 monitoring and boots-on-ground service, INET delivers “Wireless Infrastructure-as-a-Service” (W-Iaas) over the industry’s first end-to-end, private, LTE network.
The company was founded in 2011 and is based in Houston, Texas.
Materna Medical
Series A in 2016
Materna Medical, Inc. is a medical device company based in Mountain View, California, focused on developing innovative solutions to reduce maternal childbirth-related injuries during vaginal delivery. Established in 2010, the company addresses significant unmet needs in women's pelvic health, positioning itself within a $6 billion market. Materna Medical aims to transform the standard of care in obstetrics and gynecology by leveraging advanced technologies and a diverse team of engineers, scientists, and commercial leaders. The company’s mission is to empower women to safeguard their pelvic health through its novel medical devices.
Onit
Venture Round in 2016
Onit, Inc. is a developer of enterprise workflow software and artificial intelligence platforms, primarily focused on enhancing legal and compliance operations within various industries, including technology, insurance, healthcare, and finance. Founded in 2011 and headquartered in Houston, Texas, with additional offices in Austin, New Zealand, and India, the company provides a suite of applications designed to streamline business process automation. Its offerings include Enterprise Legal Management, Matter Management, Legal Spend Management, Contract Lifecycle Management, and Legal Holds, each aimed at improving efficiency and productivity in managing legal operations. Onit's no-code platform allows users to create custom applications without relying on IT support, enabling the automation of typically manual and cumbersome processes. This capability not only helps organizations reduce costs but also facilitates centralized data collection and immediate notifications to relevant parties.
Quad Technologies
Convertible Note in 2016
Quad Technologies is disrupting cell separation and cell therapy workflows by providing researchers with a simple, cell-friendly capture and release technology for cell isolation. Their new MagCloudz™ Streptavidin Cell Separation kit, featuring novel QuickGel™ technology platform, enables straightforward, scalable and fast cell separation with unique magnetic particle dissociation, resulting in complete label free cells. For applications such as T Cell purification, stem cell isolation, circulating tumor cell (CTC) separation and immunotherapy, this unique solution offers drastically improved cell viability, purity and recovery while maintaining a native cellular phenotype.
Dynamo Micropower
Angel Round in 2016
Dynamo Micropower Corporation is a technology company focused on developing innovative fuel-flexible gas turbines tailored for small distributed generation in the oil and gas industry. Founded in 2011 and headquartered in Somerville, Massachusetts, the company offers advanced power solutions, including its PowerCore system, which provides reliable, grid-quality power while operating on local unrefined gas. This capability allows customers to significantly reduce energy costs, with savings of up to 80%, and enhances equipment performance by up to 25%. Dynamo also provides custom solutions and a flameless turboheater known as Infernocore, addressing the specific needs of oilfield applications. The company distributes its products through a network of distributors and offers support services via service partners, having established a solid customer base that includes notable clients such as Kinder Morgan and Caterpillar.
Adient Medical
Series C in 2016
Founded in 2012, Adient Medical specializes in developing absorbable medical devices. Its flagship product is an absorbable vascular filter designed for preventing pulmonary embolisms, aiming to enhance patient safety and reduce complications associated with traditional implants.
Autonomous Marine Systems
Seed Round in 2016
Autonomous Marine Systems Inc. is a marine data services company based in Somerville, Massachusetts, established in 2009. The company specializes in collecting and transmitting hydrographic data utilizing low-cost, self-powered ocean surface drones that operate autonomously. These wind and solar-powered robotic sailboats are deployed in fleets to form an intelligent sensor network, enabling customized surveys for various sectors including defense, energy, shipping, fishing, and research. By providing long-duration mission capabilities over extensive geographic areas, Autonomous Marine Systems allows clients to gather crucial marine data while minimizing risks to human life and reducing the costs associated with traditional vessels in challenging marine environments.
Quad Technologies
Series A in 2015
Quad Technologies is disrupting cell separation and cell therapy workflows by providing researchers with a simple, cell-friendly capture and release technology for cell isolation. Their new MagCloudz™ Streptavidin Cell Separation kit, featuring novel QuickGel™ technology platform, enables straightforward, scalable and fast cell separation with unique magnetic particle dissociation, resulting in complete label free cells. For applications such as T Cell purification, stem cell isolation, circulating tumor cell (CTC) separation and immunotherapy, this unique solution offers drastically improved cell viability, purity and recovery while maintaining a native cellular phenotype.
Adient Medical
Seed Round in 2015
Founded in 2012, Adient Medical specializes in developing absorbable medical devices. Its flagship product is an absorbable vascular filter designed for preventing pulmonary embolisms, aiming to enhance patient safety and reduce complications associated with traditional implants.
HUVRData
Seed Round in 2015
HUVRData, LLC develops enterprise asset management software designed to enhance the return on investment for asset owners through streamlined digital maintenance and inspection processes. The company's offerings include InspectFlow, a platform for digitizing inspection checklists; ImageFlow, which aids field technicians in processing and annotating inspection images; and Anytime / Anywhere Forms, enabling on-site documentation of issues. HUVRData also provides a centralized control panel for asset management, a versatile reporting tool, and an analytics engine that delivers actionable insights and trend analysis. The company caters to the renewables, oil and gas, maritime, and utility sectors, along with service providers such as inspection and consulting firms. Founded in 2014 and headquartered in Austin, Texas, HUVRData serves a range of clients, including Fortune 500 companies, by facilitating digital transformation in asset governance and breaking down data silos.
Set.fm
Convertible Note in 2015
Set.fm, Inc. is an Austin, Texas-based company that operates an innovative online platform enabling live concert performers to capture and sell their performances immediately after the event. Established in 2012 and formerly known as DejaSet, Inc., Set.fm provides musicians with a user-friendly mobile app that allows them to record high-quality audio of their live shows, often using equipment they already possess. This technology facilitates the promotion and sale of recordings, giving artists an opportunity to generate additional revenue streams. Fans can purchase recordings of performances they attended, enhancing their experience and allowing them to relive the event long after it has concluded. Set.fm aims to support musicians and enrich the live music experience for fans worldwide.
Materna Medical
Seed Round in 2014
Materna Medical, Inc. is a medical device company based in Mountain View, California, focused on developing innovative solutions to reduce maternal childbirth-related injuries during vaginal delivery. Established in 2010, the company addresses significant unmet needs in women's pelvic health, positioning itself within a $6 billion market. Materna Medical aims to transform the standard of care in obstetrics and gynecology by leveraging advanced technologies and a diverse team of engineers, scientists, and commercial leaders. The company’s mission is to empower women to safeguard their pelvic health through its novel medical devices.
DNAtrix, Inc. is a clinical-stage biotechnology company based in Houston, Texas, with an additional office in San Diego, California. The company specializes in developing virus-driven immunotherapies for cancer treatment, focusing initially on glioblastoma, a highly aggressive and currently untreatable brain tumor. Its lead product, DNX-2401, is a modified oncolytic virus derived from a common cold virus, designed to selectively target and kill cancer cells. This innovative approach has shown promising results, with over 35 patients treated and positive early outcomes reported. In addition to DNX-2401, DNAtrix is advancing other candidates such as DNX-2440 and DNX-2450 for solid tumors, as well as MYX-135 for hematological malignancies. The company also has a strategic partnership with Valo Therapeutics, further enhancing its research and development capabilities in the field of cancer immunotherapy.
Wonder Technologies
Seed Round in 2014
Wonder Technologies, Inc. is a California-based company that operates a digital marketplace for e-gift cards, allowing consumers to discover and purchase cards from a variety of national retailers and local specialty stores across the United States. The company’s technology facilitates the redemption of these gift cards at numerous merchants, including coffee shops, restaurants, and spas, through credit card payments. Additionally, Wonder Technologies offers an iOS application that simplifies the purchasing process for customers. By leveraging card-linked solutions, Wonder enhances the digital gifting and incentives market, enabling merchants to quickly implement and assess the effectiveness of their marketing strategies while providing valuable data insights to improve customer engagement.
Cerebrotech Medical Systems
Venture Round in 2014
Cerebrotech Medical Systems, Inc. is a company specializing in the development of non-invasive monitoring technology for patients recovering from stroke or traumatic brain injury. The company's flagship product, the Cerebrotech monitor, is designed to facilitate the early detection of cerebral fluid accumulation, such as edema or bleeding, which can arise from various neurological conditions. This continuous monitoring capability provides healthcare professionals with critical information about changes in brain fluid levels before an increase in intracranial pressure occurs, enabling timely interventions to prevent potential brain damage. Founded in 2010 and headquartered in Pleasanton, California, Cerebrotech aims to enhance patient outcomes by addressing the limitations of current monitoring technologies, which are often invasive or provide only transient data.
Deep Imaging Technologies
Venture Round in 2014
Deep Imaging Technologies, Inc. is a subsurface imaging company established in 2008 and located in Tomball, Texas. The company specializes in developing advanced data collection equipment and software technologies tailored for the oil and gas industry. Its product offerings include surface imaging systems that utilize electromagnetic fields generated at very low frequencies to effectively image geological features. The combination of transmitters, receivers, and imaging software positions Deep Imaging Technologies as a key player in enhancing subsurface data acquisition and interpretation within the sector.
Autonomous Marine Systems
Seed Round in 2014
Autonomous Marine Systems Inc. is a marine data services company based in Somerville, Massachusetts, established in 2009. The company specializes in collecting and transmitting hydrographic data utilizing low-cost, self-powered ocean surface drones that operate autonomously. These wind and solar-powered robotic sailboats are deployed in fleets to form an intelligent sensor network, enabling customized surveys for various sectors including defense, energy, shipping, fishing, and research. By providing long-duration mission capabilities over extensive geographic areas, Autonomous Marine Systems allows clients to gather crucial marine data while minimizing risks to human life and reducing the costs associated with traditional vessels in challenging marine environments.
TNG Pharmaceuticals
Series A in 2014
TNG Pharmaceuticals, Inc. is a biotechnology company based in Louisville, Kentucky, focused on the development of innovative veterinary solutions. Established in 2011, the company specializes in its patented vaccine, FlyVax, which is designed to significantly reduce the population of horn flies that infest cattle. Utilizing recombinant protein technology, FlyVax works by counteracting the horn fly's anti-clotting agent, Thrombostasin, thereby inducing an immune response that promotes blood clotting at the site of the wound. TNG Pharmaceuticals originated from the University of Louisville's Entrepreneurship MBA program and has gained recognition by winning multiple global business plan competitions, showcasing its commitment to advancing agricultural health.
Payouts Network
Seed Round in 2014
Payouts Network Inc. specializes in customizable, rule-based payout and compensation solutions tailored for a digital landscape. Founded in 2013 and based in Bozeman, Montana, the company offers real-time payment services, including Instant Payouts and Point of Purchase Payouts, catering to various sectors such as customer service, loyalty rewards, dynamic payroll, and rebates. Payouts Network's proprietary enterprise platform enhances the customer experience by providing customizable payment controls, real-time data, and fraud reduction. By streamlining B2B and B2C payment processes, the company enables businesses to efficiently manage disbursements and improve interactions with customers and employees, ultimately lowering payment-related costs.
Quarri Technologies, Inc., established in 2007 and headquartered in Austin, Texas, specializes in designing and developing Web security software. The company offers solutions that protect organizations' endpoints and sensitive data, including Perimeter Shield, Data Safe, and Armored Browser. These products safeguard against malware and network-based attacks, prevent data leaks, and protect Windows systems from Web-borne threats. Quarri serves clients across North America, Europe, and the Middle East, providing security for online banking, PCI compliance, cloud applications, intellectual property, SharePoint, and enterprise SaaS.
TNG Pharmaceuticals
Seed Round in 2013
TNG Pharmaceuticals, Inc. is a biotechnology company based in Louisville, Kentucky, focused on the development of innovative veterinary solutions. Established in 2011, the company specializes in its patented vaccine, FlyVax, which is designed to significantly reduce the population of horn flies that infest cattle. Utilizing recombinant protein technology, FlyVax works by counteracting the horn fly's anti-clotting agent, Thrombostasin, thereby inducing an immune response that promotes blood clotting at the site of the wound. TNG Pharmaceuticals originated from the University of Louisville's Entrepreneurship MBA program and has gained recognition by winning multiple global business plan competitions, showcasing its commitment to advancing agricultural health.
Cinegif
Seed Round in 2013
Cinegif is an Austin-based software company that specializes in patented video conversion technology. It helps marketing professionals create engaging animated GIFs from still images and videos for web pages, emails, social media, texts, and digital signage.
AdventureLink Travel
Seed Round in 2012
AdventureLink Travel, Inc. is an online booking platform specializing in adventure travel, offering a diverse array of activities such as hiking, scuba diving, culinary experiences, and wildlife safaris across numerous global destinations. Founded in 2006 and headquartered in Altadena, California, AdventureLink aggregates a wide range of tour operators, simplifying the process for consumers and travel agents to research, compare, and book multi-day tours. This innovative platform serves as a comprehensive solution for retail partners, enabling them to introduce and capitalize on the growing market for experiential travel. With an emphasis on scalability, AdventureLink operates on a software as a service model, enhancing booking efficiencies and increasing margins as more partners utilize the system. The company is uniquely positioned within the $130 billion tour industry, catering to the rising demand from travelers seeking memorable and immersive experiences.